(Q51562010)

English

Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid.

scientific article published in July 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid. (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

coronary artery disease

1 reference

based on heuristic

inferred from title

Andrew G. Bostom

1

object named as

Bostom AG

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

9

object named as

Selhub J

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Irwin H. Rosenberg

8

object named as

Rosenberg IH

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

6

object named as

Jacques PF

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

author name string

Gohh RY

2

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Liaugaudas G

3

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Beaulieu AJ

4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Han H

5

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Dworkin L

7

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

145

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

1

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

221-224

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

The responsiveness of plasma homocysteine to small increases in dietary folic acid: a primary care study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900023-4

7 January 2021

Identifiers

10.1016/S0021-9150(99)00023-4

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 April 2018

http://europepmc.org/abstract/MED/10428313

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51562010&oldid=2094575106"